In conjunction with pharmaceutical companies,
we perform nationally designed investigational
studies on dermatologic medications. Studies are
strictly voluntary and confidential. Participants
may receive free medication, dermatologic evaluations
and financial compensation.
Ongoing Studies:
Galderma is undergoing a study with a new product
called Clobex Spray. This product is to treat patients
with moderate to severe psoriasis.
Ethica acne vulgaris study evaluating the efficacy
of systemic antibiotics and topical dual action
antibiotics.
Stiefel laboratories cystic acne vulgaris study
evaluating the efficacy of an FDA- approved topical
retinoid vs. a topical antibiotic.
Evaluation and long term study of psoriasis for
patients using immunomodulatery intramuscular injections.
To find out if you qualify for any of these studies,
call 631-265-1351 ext.110
|